Two Sigma Investments’s Immuneering IMRX Stock Holding History

Two Sigma Investments’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Buy	244,771 +37,616	+18%	+$193K	﹤0.01%	3062
2025 Q4	$1.36M	Buy	207,155 +99,284	+92%	+$637K	﹤0.01%	2722
2025 Q3	$755K	Buy	107,871 +89,318	+481%	+$464K	﹤0.01%	2762
2025 Q2	$62.5K	Sell	18,553 -17,204	-48%	-$29.5K	﹤0.01%	3049
2025 Q1	$54.4K	Sell	35,757 -14,800	-29%	-$26.9K	﹤0.01%	3037
2024 Q4	$111K	Buy	50,557 +10,126	+25%	+$21K	﹤0.01%	2955
2024 Q3	$101K	Sell	40,431 -169,594	-81%	-$247K	﹤0.01%	2898
2024 Q2	$269K	Buy	+210,025	New	+$345K	﹤0.01%	2643
2022 Q3	–	Sell	-17,138	Closed	-$93K	–	2625
2022 Q2	$93K	Sell	17,138 -34,222	-67%	-$183K	﹤0.01%	2276
2022 Q1	$332K	Buy	+51,360	New	+$493K	﹤0.01%	2180

Other funds holding IMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments's IMRX Position: Q1 2026 in Review

Two Sigma Investments increased its Immuneering (IMRX) stake by 18% in Q1 2026, buying an estimated $193K and bringing the position to 244,771 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3062.

Two Sigma Investments first reported a position in IMRX in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.36M in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

Two Sigma Investments held 244,771 shares of Immuneering worth $1.29M as of Q1 2026.
Two Sigma Investments bought 37,616 Immuneering shares in Q1 2026, an estimated $193K.
Immuneering made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3062 holding.
Two Sigma Investments first reported a position in Immuneering in Q1 2022 and has held it in 10 quarters since.
Two Sigma Investments's Immuneering position peaked at $1.36M in Q4 2025.
95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.